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inspected both online and hardcopy resources in our appraisal. A total of 147 articles were
eventually identiﬁed, only 31 articles were exclusively focused on MGS with original or
targeted research. From these, we discuss pertinent clinico-pathological features of MGS, high-
light the possible connection and interplay with HIV, and assess current diagnostic techniques
alongside consideration of their use and application in SSA. To appreciate the burden of MGS
more fully, especially in endemic areas, there is a clear need for better surveillance and longi-
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Schistosomiasis is a snail-borne disease of humans caused by parasitic helminths of the genus Schistosoma (Colley et al., 2014).
It remains a major neglected tropical disease (NTD) and a signiﬁcant public health challenge in low and middle-income countries
(Chitsulo et al., 2000; Engels et al., 2002; Christinet et al., 2016). There it causes signiﬁcant morbidity and in certain areas mor-
tality (van der Werf et al., 2003), however, the burden of schistosomiasis is underestimated due to incomplete disease surveil-
lance as undertaken by often stretched national healthcare systems and national control programmes (King et al., 2005;
Gryseels et al., 2006). The latter is more focused on tracking the delivery and treatment coverage of mass treatment campaigns
offering donated praziquantel (PZQ), typically to school-aged children (Savioli et al., 2017) rather than monitoring the disease
in adults per se. The consequences and disability caused by gender speciﬁc manifestations of urogenital schistosomiasis (UGS)
in adults often go unremarked at national and local levels. In contrast to female genital schistosomiasis (FGS), male genital schis-
tosomiasis (MGS), as evidenced by schistosome eggs (usually those of Schistosoma haematobium) in male genital organs and re-
productive tracts thereof, remains poorly reported, much understudied and often misunderstood. This review was conducted to
draw attention to the current evidence on MGS and assess its public health importance across the world.
1.1. A brief history of schistosomiasis
Corroborated references to signs and symptoms ascribed to UGS can be traced back to 1900 BCE since haematuria (i.e. frank blood in
urine)was described as a commonoccurrence and linked to ‘menstruation’ in Egyptianmales (Davis andAnsari, 1973). Schistosomiasis is
a provendisease of antiquity for S. haematobiumovahavebeen found in kidney tubules of twoEgyptianmummies from1250 to 1000BCE
(Ruffer, 1910) and more recently Schistosoma japonicum ova retrieved within Chinese cadavers dated to 206 to 220 CE (Coon, 2005).
Schistosomiasis itself was originally described in Egypt by the German pathologist Theodor Bilharz in 1851who discoveredmale and fe-
male schistosomeworms at autopsy, naming them allDistomumhaematobium. This led him to ascribe, incorrectly, that UGS and hepato-
intestinal disease were linked to this schistosome species alone (Rollinson, 2009). Some sixty years later, and again in Egypt, this unfor-
tunate mistake and subsequent confusion was fully resolved by Robert T. Leiper who demonstrated the independent lifecycles of S.
haematobium and Schistosoma mansoni (Leiper, 1916) and their respectively aetiology in urinary and hepato-intestinal disease (Leiper,
1916; Stothard et al., 2016).
Out of the 24 species of schistosomes recognised worldwide, only six cause human diseases, namely S. haematobium, S.
mansoni, S. japonicum, Schistosoma mekongi, Schistosoma intercalatum and Schistosoma guineensis (Rollinson, 2009). The ﬁrst
three species are the most important from a public health perspective. Although there may be exceptions owing to ectopic egg
laying sites, S. haematobium is exclusively associated with UGS which is widely distributed in Africa and adjacent regions, affecting
more people (112 million) than all other species [(WHO) see http://www.who.int/schistosomiasis/epidemiology/table/en/].
Schistosoma mansoni, S. japonicum and the other species causes hepato-intestinal schistosomiasis, with S. mansoni prevalent in
the Caribbean, South America and Africa and S. japonicum in Asia as South East Asia (Colley et al., 2014). Of note, S. mansoni, S.
japonicum, S. intercalatum and S. guineensis have been reported to cause genital manifestations but even collectively can be con-
sidered as minor when compared against S. haematobium alone.
1.2. Focus on male genital schistosomiasis
Male genital schistosomiasis is a speciﬁc manifestation of schistosomal disease, associated with presence of ova and patholo-
gies thereof in various genital organs and reproductive ﬂuids. The original report of MGS was made by Professor Frank Cole Mad-
den, Professor of Surgery at Kasr-el-Ainy Hospital in Cairo, Egypt. In 1911, he described a 14-year Egyptian boy having enlarged
scrotum showing epidydimal schistosomiasis and an English soldier complaining of haemospermia (blood in semen) concurrently
with urinary schistosomiasis (Madden, 1911).
Other symptoms of MGS described in literature include pelvic pain appearing spontaneously, during coitus or on ejaculation,
ejaculate changes, erection discomfort or dysfunction, infertility (Mabey et al., 2013; Farrar et al., 2014; Squire and Stothard,
2014). Although observations indicate that genital organs are frequently infested with schistosome eggs along with the urinary
bladder (S. haematobium) or intestines (S. mansoni), the current extent of morbidity associated with MGS in endemic areas re-
mains under-researched but is most clearly evidenced by post-mortem studies and case reports. By contrast, as colposcopy is
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association with human immunodeﬁciency virus (HIV) infection in women living in endemic areas of SSA (Kjetland et al., 2006;
Kjetland et al., 2012). There is a similar plausibility of additional risk of HIV transmission among dually-infected males in
schistosomiasis-endemic areas due to observed increase in inﬂammatory cells and immunological mediators in semen of people
with MGS which might increase the viral copies (Leutscher et al., 2005). Hence treatment of MGS with PZQ could support the
control of HIV/AIDS in overlapping prevalent areas of both diseases, especially in SSA.
This systematic review on MGS in endemic areas, has the following speciﬁc objectives:
1. update the epidemiology of MGS in endemic areas,
2. review the clinicopathological features of MGS including co-infections with other diseases,
3. assess the available diagnostic techniques and treatment of MGS, and
4. determine the existing gaps to develop future research agenda of MGS.
2. Methods of literature review
An online literature search was conducted systematically from January 2017 to April 2018 for publications made from 1900 up
to 2017, using the main search term ‘male genital schistosomiasis’ in PUBMED, EBSCOhost (CINAHL Complete, MEDLINE Complete,
Global Health, eBook Collection), COCHRANE LIBRARY and WEB OF KNOWLEDGE databases, following the stipulated guidelines of
each database. The main search term was combined with terms for known symptoms of MGS retrieved from the main textbooks
on Tropical Medicine (Mabey et al., 2013; Farrar et al., 2014; Squire and Stothard, 2014), which included ‘haemospermia’,
‘haematospermia’, ‘ejaculate’, ‘erectile dysfunction’, ‘infertile’, ‘sterile’, ‘painful’, ‘discomfort’, ‘spermaturia’, ‘semen’. In addition,
the main term was combined with terms of male genital organs, listed as ‘prostate’, ‘seminal vesicle’, ‘spermatic cord’, ‘epididy-
mis’, ‘vas deferens’, ‘testis’ and ‘reproductive organ’.
In the PUBMED database after inputting the main search term, it automatically searched the terms as Medical subject headings
(MeSH) and all ﬁelds, to produce the total results which were narrowed to those of English language. The search of the main
terms in the EBSCOhost database involved all possible forms of the terms, augmented using relevant syntax ‘OR’, ‘AND’; for exam-
ple, ‘male+ OR male* OR man* OR man+’ AND ‘genital+ OR genital*’ AND ‘schistosomiasis+ OR schistosomiasis* OR
Schistosoma* OR Schistosoma+ OR bilharzia+ OR bilharzia* OR bilharziosis* OR bilharziosis+’. These terms were automatically ex-
panded for equivalent subjects and related words, also narrowed by English language. The search in the COCHRANE LIBRARY
followed a similar pattern to the EBSCOhost database. For the WEB OF KNOWLEDGE, the main terms were searched using both
ﬁeld tags ‘TOPIC’ and ‘TITLE’ and then combined with Booleans ‘OR’, and ‘AND’ appropriately. The results were compiled together
to produce the ﬁnal list of articles. Additional articles from other sources such as references from the textbooks and known par-
asitologists were added to the ﬁnal lists from these four databases. The ﬁnal articles in French and Portuguese languages were
translated into English (refer to Appendix 1 Supplementary Tables).
All the articles were screened in the following ﬁve stages:
• Stage 1: Lists of articles were checked for possible duplications, which were removed.
• Stage 2: Thereafter, the titles of the remaining articles were screened for relevance to MGS, and excluded accordingly.
• Stage 3: Then, the abstracts of those remaining were read and screened for relevance to MGS. Those articles not related to MGS
were removed from the list.
• Stage 4: The full-text of the remaining articles was retrieved and read through to select those manuscripts on MGS to be in-
cluded in the review.
• Stage 5: The references of the full-text articles included in the review were screened for additional articles not retrieved in the
above database searches.
Furthermore, leading articles on FGS and texts from prominent textbooks describing schistosomiasis (Gelfand, 1967; Jordan
and Webbe, 1969; Jordan et al., 1993; Kamel and Lumley, 2004; Weiss, 2004) were read to form background knowledge and com-
parison to MGS where necessary. Alerts were installed on all the databases searched for this review to capture new publications
and additional articles relevant to MGS.
3. Analysis of assembled literature
The online database search produced a combined total of 3329 publications using the main search term (Fig. 1 & Table 1). Four
articles were added from the alerts on the searched databases. After screening through the ﬁve stages described earlier, the ﬁnal
articles included in this MGS review are 151 (Appendix 1 Supplementary Table 2), of which 32 were original research studies, 96
case reports, 2 editorial papers, 3 systematic reviews, and 18 literature reviews on schistosomiasis with aspect of male genital pa-
thology. The period of publications was from 1911 to 2018.
Thirty-two original research studies have been published from 1952, with half directly on genital schistosomiasis, while the
other half focussed on schistosomiasis with brief descriptions on genital symptoms, pathologies or complications. Sixteen studies
reported only on S. haematobium, 3 on S. mansoni, 9 on mixed S. haematobium and S. mansoni infections, while 4 had no mention
of species (Fig. 3). In addition, 26 studies were conducted in Africa [Madagascar-6, Nigeria-6, Egypt-5, Zimbabwe-5, Zambia-2,
Ghana-1] and one each in other continents except Australasia. There were 11 necropsy studies, 5 histopathological studies, 6
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Fig. 1. Flow chart showing the results of the systematic literature search in the online databases.
4 S. Kayuni et al. / Parasite Epidemiology and Control 3 (2018) e00077longitudinal cohort studies, 2 qualitative studies, 1 radiography study and 1 hormonal analysis study. Seven studies involved ex-
amination of all genital organs, 2 on seminal vesicles, 1 on prostate only while other studies did not focus on speciﬁc genital organ
(s).Table 1
Results of literature search on the online databases conducted from January 2017 to April 2018.
Online database Number of articles from each database
‘male genital schistosomiasis’ Combined with ‘symptoms’ Combined with ‘symptoms’ and ‘organs’
EBSCOhost 680 837 1677
PUBMED 181 339 812
WEB OF KNOWLEDGE 140 275 570
COCHRANE LIBRARY 17 96 270
TOTAL 1018 1547 3329
Fig. 2. Global map showing distribution of the publications on MGS from 1911 to 2018. The two charts displaying number of publications in the ﬁrst and second 50 years and per continent. (The original research studies
comprise post-mortem studies conducted in Africa and South America; prospective studies mainly in Africa.)
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ports were from endemic areas mostly in Africa [n = 35; 64%] while 40 reports were on travellers or people emigrating from en-
demic areas to non-endemic countries, especially in Europe [n = 30; 75%] (Fig. 2). Some travellers diagnosed in non-endemic
countries in Europe, Asia and Australia, were infected after swimming or walking in Lake Malawi in SSA, which is endemic mainly
for S. haematobium. In France, ten of the 12 case reports were of travellers to or emigrants from North, West and Central African
countries of Algeria, Cameroun, Central African Republic, Chad, Democratic Republic of Congo (DRC), Egypt, Gabon, Libya, Mali,
Mauritania, Niger and Tunisia.
Sixty case reports (63%) were on S. haematobium, 22 (23%) on S. mansoni, and the rest (5%) on mixed S. haematobium and S.
mansoni (n = 2), on S. haematobium, S. mansoni and S. intercalatum (n = 2), on S. japonicum (n = 1), whereas 9 (10%) had no
speciation. The pathological organs described in 74 case reports included scrotum (including testis and vas deferens) [n = 39],
prostate [n = 17], seminal vesicles [n = 17], spermatic cord [n = 3], epididymis [n = 7] and penis [n = 1]. The main presenting
symptoms or complaints were swelling of scrotum and other genital organs [n = 58], pelvic pain [n = 23], haemospermia [n =
14], hydrocele [n = 12], changes in semen/ejaculate [n = 11], infertility [n = 6] and urethral discharge [n = 2].
The 3 systematic reviews were published in 2011 and 2015, discussing the relationship between UGS and HIV (Mbabazi et al.,
2011), prostate adenocarcinoma associated with prostatic S. haematobium infection (Figueiredo et al., 2015) and MGS treatment
as a future HIV prevention tool (Stecher et al., 2015).3.1. Update on the epidemiology of MGS
As described earlier, S. haematobium is endemic in Africa, particularly SSA, where most knowledge originates and the ﬁrst
recognised description of MGS was made by Madden a century ago (Madden, 1911). However, earlier literature by Chaker, Lortet,
Vialleton, Letulle and Madden [1885–1909] described lesions in genital organs like seminal vesicles and prostate which were in-
ﬁltrated by schistosome ova and granulomata formation (Madden, 1909; Mensah et al., 1972; Guirassay et al., 2008). Other genital
organs have been described in the subsequent reports and research studies.
Post-mortem studies were among the earliest research in endemic areas especially in Africa, describing the epidemiology of
genital schistosomiasis, four decades after the Madden report, giving the background knowledge to understanding MGS
(Mohammed, 1952; Gelfand and Ross, 1953; Edington et al., 1970; Gelfand et al., 1970; Edington et al., 1975). Digestive methods
were performed using potassium hydroxide (KOH) to harvest the ova from the genital organs with pathologies caused by S.
haematobium and S. mansoni. Seminal vesicles were infected almost as much as the urinary bladders, ranging from 50% to 80%
of vesicles with over 90% of bladders (Mohammed, 1952; Gelfand and Ross, 1953) with approximately 20,000 ova found in the
vesicles [Table 2] (Edington et al., 1970; Gelfand et al., 1970; Edington et al., 1975). Histopathological examinations were also con-
ducted, in other studies to compare with the digestive methods which showed that more ova were observed with the latter tech-
nique (Gelfand et al., 1970).
In endemic areas of S. haematobium and S. mansoni, the former predominates with more genital pathologies in literature than
the latter, similarly to the case reports (Grace and Aidaros, 1952; Alves et al., 1955). From these studies, it has been described that
MGS affects between 1% to 20% of those in endemic areas at risk and suffering from UGS (Ricosse et al., 1980; Fievet et al., 1984).
This could be a gross underestimation, because several studies have reported that at least 50% of genital organs are infected by
schistosome ova, emphasising that MGS is as common as urinary manifestations of schistosomiasis but with lower intensity of
ova [Table 3] (Edington et al., 1970; Edington et al., 1975; Elem and Patil, 1987; Patil and Elem, 1988).
The ﬁrst identiﬁed prospective study on MGS was conducted in Madagascar in 1999–2000, where 19 of 44 participants (43%)
had MGS by S. haematobium ova in semen (Leutscher et al., 2000). Although the sample size of this study was small, subsequent
longitudinal studies in the same country showed similar prevalence of MGS, ranging from 28% in 2005 to 53% in 2009 (Leutscher
et al., 2005; Leutscher et al., 2008a; Leutscher et al., 2008b; Leutscher et al., 2009). Schistosoma ova were present in semen only in
some cases, highlighting fact that the prevalence of MGS is quite signiﬁcant, similarly to that of UGS in endemic areas, despite not
having been studied as extensively.Table 2
Total number of Schistosoma ova in pelvic organs in necropsy studies.
Study participants Post-mortem studies
Gelfand et al., 1970 Edington et al., 1975
Total number 200 54
Pelvic organs Intensity of Schistosoma egg distribution
Gelfand et al., 1970 Edington et al., 1975
Bladder 105,011 13,260–87,100
Seminal vesicles 19,801 4312–12,027
Vas deferens 2913 –
Prostate 34 169–9828
Table 3
Schistosoma ova in male genital organs seen in necropsy studies.
Year Author(s) Country Autopsies Species Infected genital organs
1955 Alves et al. Zimbabwe 50 Sh, Sm 18% vas deferens; 18% prostate; 4% tunica vaginalis; 2% epididymis
1956 Arban Brazil 3233 Sm 10/3233 infected: 20% prostate; 30% testes
1970 Gelfand et al. Zimbabwe 200 Sh, Sm 54% seminal vesicles; 39.9% spermatic duct; 20.5% prostate
1975 Edington et al. Nigeria 54 Sh Severe infections: 100% prostate; 100% seminal vesicles; 57% testes; 57% epididymis
1987 Elem & Patil Zambia 50 Sh 62% bladder; 58% seminal vesicles; 50% prostate
1988 Patil & Elem Zambia 100 Sh 62% bladder; 58% seminal vesicles; 50% prostate
Sh - S. haematobium; Sm - S. mansoni.
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From our search, genital organs with schistosomal pathologies have been recorded in case reports from Africa, namely pros-
tate, seminal vesicles, vas deferens, testis and scrotum which were more associated with S. haematobium than S. mansoni
(Cerqua, 1930; Mohammed, 1930; Makar, 1937; Gelfand and Davis, 1940). An early report from South America associated with
S. mansoni, presented of enlarged scrotum, thickened seminal vesicles and hydrocele (Armbrust, 1951). Subsequent reports indi-
cate that a higher burden of MGS is in S. haematobium - endemic areas of Africa than other schistosome - endemic areas in the
world.
Although most of the MGS pathologies have been reported on S. haematobium in inhabitants and travellers to endemic areas,
similar reports have been made on S. mansoni, S. intercalatum and S. japonicum (Corachan et al., 1994; Vilana et al., 1997; Yu et al.,
2013). Infestation of genital organs results in several early symptoms of MGS. One major symptom observed in early stages is
haemospermia resulting from egg penetration and release into seminal vesicle lumen, causing ulceration of mucosal lining, and
pain during coitus and ejaculation (Madden, 1911; Makar, 1937; Mohammed, 1952; Kato-Hayashi et al., 2013; Lang et al.,
2017). Haemospermia can occur as the only symptom or ﬁrst symptom preceding haematuria, occurring within three months
of exposure to infection (Becquet, 1966; Pedro Rde et al., 1973; Corachan et al., 1994; Schwartz et al., 2002).
Of interest, this symptom has been described more frequently among travellers than inhabitants of endemic areas, in 8 of the
12 case reports found in the search. This could be due to failure to recognise the symptoms, societal acceptance of condition as
male menstruation and maturing from boyhood to adulthood, not knowing or making an association with MGS, being mistaken
with sexually transmitted infections (STIs) or inﬁdelity (Ukwandu and Nmorsi, 2004; Yirenya-Tawiah et al., 2016). In relation to
haemospermia, other reported symptoms include alteration in semen quality and appearance with discolouration (McKenna et al.,
1997; Torresi et al., 1997; Hawary et al., 2012), subjective change (Davies and Hamdy, 1998), lumpy semen (Lewis et al., 1996;
Lang et al., 2017), rice grains with increased volume (Pedro Rde et al., 1973) and reduced viscosity or volume (Perignon et al.,
2007; van Delft et al., 2007; Knapper et al., 2012).
The symptoms associated with mucosal thickening and enlargement of organs such as seminal vesicles cause irritation of the
sympathetic nervous system leading to sexual hyperexcitability, night dreams and frequent painful erections (Mohammed, 1952).
However, these symptoms have not been reported in the last four decades, raising the question of their reliability in the earlier
studies or non-reporting in the recent studies, possibly due to the sensitive descriptive nature. The enlargement of genital organs
has also been mistaken for other diseases such as tuberculosis or malignancy resulting in extraneous surgical interventions where
PZQ treatment provided earlier might have prevented the surgery (Madden, 1911; Chippaux et al., 1957; Eltayeb, 1969; Kazzaz
and Salmo, 1974; Fievet et al., 1984; Githae, 1992; Ferreira et al., 2015). Untreated, the organs chronically become nodular, ﬁrmer,
smaller and non-functional.
More recently reported symptoms of MGS include spermaturia (sperm in urine) as a result of ﬁbrosis and abnormal cystic dilatation
of seminal vesicles (Etribi et al., 1967), hydrocele formation (Gelfand and Davis, 1940; Armbrust, 1951; Van Beukering and Vervoorn,
1956; Pawel et al., 2008; Ramarakoto et al., 2008; Rambau et al., 2011), epididymitis (Alves et al., 2004), funiculitis (Durand et al.,
2004), orchitis (Mikhail et al., 1988; Ihekwaba, 1992; Al-Qahtani and Droupy, 2010), prostatitis (Cerqua, 1930; Alexis and Domingo,
1986; Patil and Elem, 1988; Cohen et al., 1995; Fender et al., 1996; Basilio-de-Oliveira et al., 2002; Al-Saeed et al., 2003; Lambertucci
et al., 2006; Bacelar et al., 2007; Sharma et al., 2015), infertility from oligospermia, azoospermia either obstructive from blockage of
vas deferens, spermatic cord, epididymis, tunica vaginalis or non – obstructive through infarction (Kini et al., 2009; Abdel-Naser et al.,
2018a; Abdel-Naser et al., 2018b), ﬁbrotic lesions (Edington et al., 1975) or functional lymphotic inﬁltration in testis (Adisa et al.,
2012). While egg load in the bladder tissue has been found to correlate with pathological severity, few ova in seminal vesicles, prostate
and other genital organs have been associated with severe extensive pathological changes (Edington et al., 1970; Edington et al., 1975).
On malignancies of genital organs, our search showed that MGS has been reported among travellers and those emigrating
from endemic areas, apart from testicular or scrotal schistosomiasis simulating neoplasia (Alexis and Domingo, 1986; Cohen
et al., 1995; Ma and Srigley, 1995; Basilio-de-Oliveira et al., 2002; Bacelar et al., 2007; Lopes et al., 2007; Figueiredo et al.,
2015). Prostatic adenocarcinoma has been observed to occur together with Schistosoma ova, resulting in epithelial granulomata,
marked ﬁbrosis and organ enlargement, which have been described in reports of tissue histopathology and cancer spread to
other genital organs affected by MGS. Despite an accepted link between chronic UGS and squamous cell carcinoma of the bladder
(Honeycutt et al., 2014), the mechanism of association between prostatic cancer and schistosomiasis remains unknown.
Our search produced recent systematic reviews addressing extensively the interactions of both MGS and HIV and were in-
cluded in this review (Mbabazi et al., 2011; Stecher et al., 2015). As one of the leading causes of morbidity and mortality in
Fig. 3. Map of Africa showing the correlation of the prevalence of HIV and schistosomiasis. Produced from (WHO, 2014; Kaiser-Family-Foundation, 2016).
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male genital schistosomiasis (FGS) has been observed in 33–75% of women having UGS living in endemic areas in SSA
(Kjetland et al., 2012). In addition, FGS has been associated with a 3-fold increased risk of HIV infection with characteristic
sandy-grainy patches present in egg-infected genital organs, abnormal blood vessel formation and increased levels of inﬂamma-
tory cells expressing CD4+ receptors triggered by Schistosoma granulomata (Kjetland et al., 2006; Christinet et al., 2016). More
research and gleamed knowledge on the risk and interplay of MGS with HIV infection is needed.
Various hypotheses have been proposed regarding the impact of MGS on HIV transmission. As described in Leutscher et al.
(2005) study and the systematic reviews by Mbabazi et al. (2011) and Stecher et al. (2015), men with MGS have elevated levels
of eosinophils and lymphocytes among other inﬂammatory cells expressing CD4+ receptors together with cytokines IL-4, 6, 10,
TNF-α. These recruit more HIV-infected cells into semen, upregulating viral replication and increasing viral concentration
(Leutscher et al., 2005; Mbabazi et al., 2011; Stecher et al., 2015). With the chronic inﬂammation and cell recruitment to the
male genital tract, these may increase HIV viral load in semen, similar to that seen with STIs (Mabey, 2000). A recent observa-
tional pilot study in endemic SSA area demonstrated a reduction of viral load shedding in semen of HIV positive men coinfected
with UGS 10 weeks after PZQ treatment (Midzi et al., 2017). Further case-cohort or randomized studies are needed to be con-
ducted in endemic areas to explore these critical ﬁndings further.
3.3. Techniques for detection of MGS
Urinemicroscopy remains the deﬁnitiveway for identifying schistosome ova (mainly of S. haematobium) to diagnose UGS.While it is
the gold standard (Le and Hsieh, 2017) and also considered as a useful proxy for diagnosingMGS, our ﬁndings indicate challenges in its
reliability due to presence of ova in semenor histological specimens in the absence of ova in urine (or stool), aswell as other schistosome
species that may on occasion cause MGS (Corachan et al., 1994; Torresi et al., 1997; Leutscher et al., 2000; Schwartz et al., 2002; Lang
et al., 2017). As such, there is a direct need to conduct microscopy on semen and biopsy material from suspicious genital lesions/tissues
to diagnoseMGS. Also, semen should be analysed repeatedlywith periods of abstinence to cater for the daily diurnal variations in excre-
tion of ova from the genital organs and increase likelihood of maximum egg yield, similar to the recommended consecutive urine anal-
yses (Leutscher et al., 2008b; Le and Hsieh, 2017). However, local perceptions, beliefs and sensitivity of people in endemic communities
needs careful considerationwith regards to ejaculation and handling semen samples. Combined this can affect the collection or submis-
sion and later analyses, thus to optimise the process there is usually a need for more health education and counselling of those required
to submit as well as within the community to ensure acceptability and success in engagement alongside collection of the samples in the
community (Price et al., 2005; Midzi et al., 2017).
Leutscher and colleagues report on use of eosinophil cationic protein (ECP), circulating anodic antigen (CAA) and soluble egg
antigen (SEA) as blood-based markers of MGS which showed positive correlation to urine egg count, with ECP signiﬁcantly cor-
relating with urine count and declining after PZQ treatment, highlighting its importance in diagnosis (Leutscher et al., 2000;
Leutscher et al., 2008b). However, other helminth, bacterial or viral infections and inﬂammatory conditions elevate ECP hence af-
fecting the reliability in co-morbidities which are common in endemic areas. PCR and DNA-based tests on the other hand have
shown to be highly sensitive and speciﬁc diagnostic tools, which can be used in urine, semen, and many other specimens (Le
and Hsieh, 2017). These tests are still expensive for ﬁeld use in endemic areas of Sub-Saharan Africa, hence the need to develop
easier, accessible, low-cost tests.
Our ﬁndings showed that ultrasonography is useful in diagnosing lesions caused by MGS and monitoring morbidity of the pa-
thologies (Richter, 2000; Al-Saeed et al., 2003; Ramarakoto et al., 2008). The pathological lesions seen in genital organs have been
described as echogenic lesions and calciﬁcations, with the former improving with treatment (Richter, 2000; Ramarakoto et al.,
9S. Kayuni et al. / Parasite Epidemiology and Control 3 (2018) e000772008). Availability of portable sonography machines could be more cost-effective in endemic areas since other radiological tech-
niques such as computerised tomography (CT) and magnetic resonance imaging (MRI) are very expensive, not feasible and almost
non-existent in these regions. However, there has been limited radiological research on MGS in endemic areas, hence there is a
need for more ﬁeld studies to study the resolution of pathologies after treatment.
3.4. Current treatment options for MGS
Praziquantel (typically offered at 40 mg/kg) has remained the mainstay treatment for most forms of schistosomiasis, including
MGS (WHO, 2013). It is effective with population cure rates of over 90% and targets adult worms thereby reducing egg excretion
and averting morbidity, however, praziquantel does not successfully kill juvenile worms (Rollinson, 2009). Most identiﬁed case
reports and studies used the recommended traditional dosage of 40 mg/kg in treating MGS with some failure cases requiring fur-
ther repeated doses or higher dose of 60 mg/kg (Schwartz et al., 2002; Alonso et al., 2006; Perignon et al., 2007). It has been sug-
gested that higher doses are more efﬁcacious in MGS treatment than the traditional dose alongside shorter intervals between
retreatments, for example, 2–3 times a year (Lang et al., 2017).
Use of PZQ in most African programmes is based on morbidity control through mass drug administration versus speciﬁc case
management. The former is an attempt to keep prevalence and intensity down to an acceptable level, below 10% in the endemic
population and obtain the greatest cost-beneﬁt outcome at population level. There are well-known gaps in this approach, for ex-
ample, school-aged children are targeted with donated stocks of PZQ ring-fenced (restricted) for this use in school-based
programmes. As an indirect consequence, many adolescents and adults rarely receive adequate treatment and PZQ is not always
available in peripheral health clinics which further affects management of schistosomiasis in an individual case management set-
ting (Christinet et al., 2016; McManus et al., 2018).
3.5. Existing gaps for further research of MGS
This review conducted a systematic search to elucidate the burden of MGS in endemic areas, a century after the ﬁrst
recognised report in 1911. Despite the detailed epidemiology of schistosomiasis in the world highlighting the enormous impact
of UGS, much remains unknown of the burden of genital manifestations of schistosomiasis either FGS or MGS, speciﬁcally.
More description and research studies of UGS especially in endemic areas have concentrated on urinary system and associated
pathologies, however, with the growing interest in cervical cancer screening there are opportunities to integrate surveillance of
FGS (Christinet et al., 2016). On the other hand, for men, no such screening programmes exist and therefore the prevalence
and morbidity of MGS in endemic areas will remain under-reported.
In addition, the limited description of MGS is compounded by difﬁculties in diagnostic techniques and approaches, these in-
clude deﬁcits in standardised protocols for analysis of semen. Indeed, future methods which involve molecular assays will be chal-
lenging to carry out in primary health facilities in SSA. Future research studies to explore the deployment of low-cost techniques
and methods are urgently required. These would be particularly important regarding treatment and management of MGS, as cur-
rently there is a clear gap in our understanding of the optimal dose of PZQ to treat MGS, whether single, repeated (i.e. 2–3 times a
year) or higher dosages (i.e. N60 mg/kg) would be effect a parasitological cure (Schwartz et al., 2002; Alonso et al., 2006; Lang
et al., 2017), notwithstanding tracking the dynamics of lesions in the genital tract. This highlights the need for further prospective
longitudinal studies in endemic areas and more clinical research exploring an agenda of how best to integrate preventive treat-
ment and management of MGS alongside ongoing interventions for HIV in SSA.
4. Discussion
This review has revealed that genital organs are infested with schistosome ova in the early stages of the infection, similar to other
forms of the disease. These organs are infectedwith substantial numbers of ova asmuch as urinary bladder or intestines, further indicat-
ing the higher levels ofMGS in endemic areas. Clinicalmanifestations associatedwithMGS in this reviewhave beendescribedpreviously
by Barlow after self-infection with cercariae (Barlow andMeleney, 1949) and are regarded as major symptoms and diagnostic for MGS.
Symptoms like haemospermia can also present in other diseases such as hypertension, prostatitis or STIs (Feldmeier et al., 1999), raising
the need to exclude other conditions before concluding the diagnosis of MGS. Underreporting and misconceptions of these symptoms
which may have negative perception in the community, contribute to misdiagnosis and underestimation of MGS in these endemic
areas (Ukwandu and Nmorsi, 2004; Yirenya-Tawiah et al., 2016). Furthermore, co-existence of MGS and prostatic metaplasia and ma-
lignancies require further research to understand the link, and develop diagnostic and therapeutic interventions.
Although urine microscopy has been considered as a proxy for diagnosing MGS, our ﬁndings observed challenges of ova found
only in semen without any in urine or stool, hence the need to consider semen microscopy as a deﬁnitive way of diagnosing MGS.
Accessible, low-cost molecular tests should be developed to address this diagnostic challenge. Similarly, radiological techniques
like ﬁeld-based ultrasonography should be rolled out into endemic areas to monitor the morbidity and resolution of MGS pathol-
ogies. MGS appears to be prevalent in areas endemic for UGS, which coincidentally are high prevalent areas for HIV. Some people
in these areas in SSA have higher HIV prevalence and also at higher risk for schistosomiasis due to their lifestyles and daily activ-
ities, as reported about ﬁshermen in Malawi (NSO, 2014; NAC, 2015). With some evidence of MGS potentially upregulating viral
replication, increasing the concentration of HIV particles in the semen and exponentiating the infectiousness of dually infected
males, treatment of MGS could be an importance tool in helping to avert new HIV infections in SSA (Stecher et al., 2015).
10 S. Kayuni et al. / Parasite Epidemiology and Control 3 (2018) e00077Interestingly, one of the current effective intervention of HIV prevention, male circumcision, was considered by ancient Egyptians
around 2300 BCE as an intervention to prevent schistosomal infection among men bathing in infested waters, though later dis-
puted (Allen, 1909; Madden, 1919; Jordan, 2000; Weiss, 2004).
5. Conclusion
MGS is an under-appreciated manifestation of UGS and has been reported worldwide but its current distribution is most
tightly linked with areas endemic for S. haematobium. In SSA, MGS likely blights the lives of millions of men who currently do
not have adequate access to point-of-care diagnostics or access to optimal praziquantel treatment regimes. We propose that
MGS should be considered speciﬁcally in a new light of individual case management approaches as being used for other NTDs.
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